ICU Girisim Sermayesi Yatirim Ortakligi A.S.
ICU Girisim Sermayesi Yatirim Ortakligi A.S. is a venture capital investment trust specializing in seed/startup, early, mid venture, middle market, buyouts, PIPEs investments in small and medium enterprises. The fund seeks to invest in healthcare including all areas except hospital services (medical equipment, pharma, distribution, logistics, consumables, IT, laboratories, insurance, and payment … Read more
Market Cap & Net Worth: ICU Girisim Sermayesi Yatirim Ortakligi A.S. (ICUGS)
ICU Girisim Sermayesi Yatirim Ortakligi A.S. (IS:ICUGS) has a market capitalization of $28.42 Million (TL1.01 Billion) as of March 18, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #48374 globally and #544 in its home market, demonstrating a 2.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s stock price TL2.90 by its total outstanding shares 347500000 (347.50 Million).
ICU Girisim Sermayesi Yatirim Ortakligi A.S. Market Cap History: 2015 to 2026
ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s market capitalization history from 2015 to 2026. Data shows growth from $11.17 Million to $28.42 Million (9.86% CAGR).
ICU Girisim Sermayesi Yatirim Ortakligi A.S. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
19.43x
ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s market cap is 19.43 times its annual revenue
2.90x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $256.74 Million | $13.21 Million | -$7.42 Million | 19.43x | N/A |
Competitor Companies of ICUGS by Market Capitalization
Companies near ICU Girisim Sermayesi Yatirim Ortakligi A.S. in the global market cap rankings as of March 18, 2026.
Key companies related to ICU Girisim Sermayesi Yatirim Ortakligi A.S. by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #136 globally with a market cap of $135.78 Billion USD.
- INVESTOR B (FRIA) O.N. (F:IVSD): Ranked #247 globally with a market cap of $82.23 Billion USD ( €80.11 Billion EUR).
- Blackstone Group Inc (NYSE:BX): Ranked #256 globally with a market cap of $79.65 Billion USD.
- Brookfield Corp (NYSE:BN): Ranked #278 globally with a market cap of $75.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | BlackRock Inc | NYSE:BLK | $135.78 Billion | $943.26 |
| #247 | INVESTOR B (FRIA) O.N. | F:IVSD | $82.23 Billion | €32.80 |
| #256 | Blackstone Group Inc | NYSE:BX | $79.65 Billion | $107.12 |
| #278 | Brookfield Corp | NYSE:BN | $75.33 Billion | $39.14 |
ICU Girisim Sermayesi Yatirim Ortakligi A.S. Historical Marketcap From 2015 to 2026
Between 2015 and today, ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s market cap moved from $11.17 Million to $ 28.42 Million, with a yearly change of 9.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL28.42 Million | +11.11% |
| 2025 | TL25.58 Million | -90.04% |
| 2024 | TL256.74 Million | +188.86% |
| 2023 | TL88.88 Million | +102.00% |
| 2022 | TL44.00 Million | +145.36% |
| 2021 | TL17.93 Million | -50.54% |
| 2020 | TL36.26 Million | +210.92% |
| 2019 | TL11.66 Million | +80.30% |
| 2018 | TL6.47 Million | -41.07% |
| 2017 | TL10.98 Million | +1.82% |
| 2016 | TL10.78 Million | -3.51% |
| 2015 | TL11.17 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of ICU Girisim Sermayesi Yatirim Ortakligi A.S. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.42 Million USD |
| MoneyControl | $28.42 Million USD |
| MarketWatch | $28.42 Million USD |
| marketcap.company | $28.42 Million USD |
| Reuters | $28.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.